Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Meeting the demand for pediatric clinical trials.

Literature DB >> 24622511

Meeting the demand for pediatric clinical trials.

Edward M Connor¹, William E Smoyer, Jonathan M Davis, Anne Zajicek, Linda Ulrich, Mary Purucker, Steven Hirschfeld.

Abstract

High-quality, cost-effective pediatric clinical trials require a robust research and regulatory infrastructure and a properly trained workforce.

Entities: Disease Species

Mesh：

Year: 2014 PMID： 24622511 PMCID： PMC4104358 DOI： 10.1126/scitranslmed.3008043

Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956

4 in total

1. More than baby steps: perspectives on pediatric translational research.

Authors: Edward Connor; Donald Lombardi; John van den Anker
Journal: Sci Transl Med Date: 2009-10-14 Impact factor: 17.956

2. What's needed is a health care system that learns: recommendations from an IOM report.

Authors: Mark Smith; George Halvorson; Gary Kaplan
Journal: JAMA Date: 2012-10-24 Impact factor: 56.272

3. Achieving a nationwide learning health system.

Authors: Charles P Friedman; Adam K Wong; David Blumenthal
Journal: Sci Transl Med Date: 2010-11-10 Impact factor: 17.956

4. Why most published research findings are false.

Authors: John P A Ioannidis
Journal: PLoS Med Date: 2005-08-30 Impact factor: 11.613

4 in total

9 in total

Review 1. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.

Authors: Craig A Sable; D Dunbar Ivy; Robert H Beekman; Helene D Clayton-Jeter; Kathy J Jenkins; William T Mahle; William R Morrow; Mary Dianne Murphy; Robert M Nelson; Geoffrey L Rosenthal; Norman Stockbridge; David L Wessel
Journal: Circ Cardiovasc Qual Outcomes Date: 2017-07

2. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.

3. Sponsors meet scientists to speed pediatric medicines development.

Authors: Jonathan M Davis; William E Smoyer; Edward M Connor; W Charles Huskins; Cindy Pastern; Mary Purucker; Elisabeth C Schrader; Cynthia R Jackson; Frederick J Kaskel; Steven Hirschfeld
Journal: Sci Transl Med Date: 2015-03-18 Impact factor: 17.956

Meeting the demand for pediatric clinical trials.

1. More than baby steps: perspectives on pediatric translational research.

2. What's needed is a health care system that learns: recommendations from an IOM report.

3. Achieving a nationwide learning health system.

4. Why most published research findings are false.

Review 1. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.

2. 2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.

3. Sponsors meet scientists to speed pediatric medicines development.

4. Perceived Barriers to Clinical Trials Participation: A Survey of Pediatric Caregivers.

5. Perceived Barriers to Pediatric Clinical Trials Implementation: A Survey of Health Care Staff.

Review 6. Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

Review 7. Clinical cardiac regenerative studies in children.

8. How to Conduct Clinical Trials in Children: A Tutorial.

Review 9. How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians.